Sugi Predict

Sugi Predict / Compounds / SCHEMBL4276463

SCHEMBL4276463

SCHEMBL4276463

COc1cc(F)c2nccc(O)c2c1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TUBB1 Q9H4B7 1/20 0.37
▸ RET P07949 2/20 0.34
▸ KIF5B P33176 2/20 0.34
▸ KDR P35968 2/20 0.34
▸ RAF1 P04049 1/20 0.34
▸ BRAF P15056 1/20 0.34
▸ FGFR3 P22607 1/20 0.33
▸ MAOB P27338 1/20 0.33
▸ TRPA1 O75762 1/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ HSP90AA1 P07900 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ MMP14 P50281 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ RIPK2 O43353 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4284799 0.81 NSD2 (0.39) MAOBTRPA1MEN1KMT2AMAPT
SCHEMBL24715842 0.78 SLC6A3 (0.39) TUBB1RETKIF5BKDRRAF1
Oxalic Acid SCHEMBL4272375 0.77 DHODH (0.36) FGFR3MEN1KMT2AMAPK1HTT
SCHEMBL4270023 0.73 SLC40A1 (0.34) KDM4EHTT
SCHEMBL31550538 0.71 MAPT (0.41) TUBB1MEN1HSP90AA1KMT2AKDM4E
SCHEMBL16742836 0.70 KDM4E (0.46) MEN1KMT2AKDM4EMAPTTDP1
SCHEMBL2923376 0.70 NOS3 (0.40) TRPA1MEN1HSP90AA1KMT2AKDM4E
SCHEMBL24715776 0.68 DYRK1A (0.39) MEN1HSP90AA1KMT2AKDM4EMAPT
SCHEMBL11546694 0.68 NSD2 (0.44) MAOBKDM4EMAPTSMN1; SMN2TDP1
SCHEMBL24008901 0.67 RET (0.44) RETKIF5BKDRRAF1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534793-B2 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity SMITHKLINE BEECHAM P.L.C. (GB) 2009-05-19 — — US disclosed
US-20060014749-A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity SMITHKLINE BEECHAM P.L.C. 2006-01-19 — — US disclosed
US-6962917-B2 Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity SMITHKLINE BEECHAM P.L.C. (GB) 2005-11-08 — — US disclosed
US-20040038998-A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity SMITHKLINE BEECHAM P.L.C. (GB) 2004-02-26 — — US disclosed
EP-1305308-A1 AMINOPIPERIDINE QUINOLINES AND THEIR AZAISOSTERIC ANALOGUES WITH ANTIBACTERIAL ACTIVITY SMITHKLINE BEECHAM PLC (GB) 2003-05-02 — — EP disclosed
WO-2002008224-A1 AMINOPIPERIDINE QUINOLINES AND THEIR AZAISOSTERIC ANALOGUES WITH ANTIBACTERIAL ACTIVITY SMITHKLINE BEECHAM P.L.C. (GB) 2002-01-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038998-A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity AZI2, AMPD2, AMPD1 TUBB1 313/4885RET 4730/4885KIF5B 4314/4885
US-20060014749-A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity AZI2, NPEPPS, AMPD2 TUBB1 268/4885RET 4735/4885KIF5B 4131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.